Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags Synthon Biopharmaceuticals

Tag: Synthon Biopharmaceuticals

MacroGenics and Synthon Biopharmaceuticals Sign Agreement

Peter Hofland
MacroGenics and Synthon Biopharmaceuticals have signed an agreement  to license and collaborate in he development of MGC018, an antibody-drug conjugate or ADC directed against...

Anti-HER2 ADC SYD985 to be Evaluated in Expanded Cohort of HER2+...

Peter Hofland
Dutch pharmaceutical company Synthon Biopharmaceuticals has initiated the second part of an ongoing phase I clinical trial with its investigational anti-HER2 antibody-drug conjugate or ADC,...

Antitope and Synthon Collaborate In Assessing the Potential Immunogenicity of Candidate...

ADC Review | Editorial Team
Cambridge (UK) based Antitope, a subsidiary of Abzena, has signed an agreement to  collaborate with Synthon Biopharmaceuticals, a global pharmaceutical company based in Nijmegen,...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X